Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
McKesson
Boehringer Ingelheim
Healthtrust
Covington
Fish and Richardson
Harvard Business School
Farmers Insurance
Argus Health

Generated: April 26, 2018

DrugPatentWatch Database Preview

CHOLOGRAFIN SODIUM Drug Profile

« Back to Dashboard

When do Cholografin Sodium patents expire, and when can generic versions of Cholografin Sodium launch?

Cholografin Sodium is a drug marketed by Bracco and is included in one NDA.

The generic ingredient in CHOLOGRAFIN SODIUM is iodipamide sodium. There is one drug master file entry for this compound. Additional details are available on the iodipamide sodium profile page.
Summary for CHOLOGRAFIN SODIUM
Drug patent expirations by year for CHOLOGRAFIN SODIUM
Synonyms for CHOLOGRAFIN SODIUM
2618-26-0
3J6WZA9PXS
AC1L2A2K
ACM2618260
AK397862
AKOS027382513
AM000507
BENZOIC ACID, 3,3'-(ADIPOYLDIIMINO)BIS(2,4,6-TRIIODO-, DISODIUM SALT
Benzoic acid,3,3'-[(1,6-dioxo-1,6-hexanediyl)diimino]bis[2,4,6-tri(iodo-131I)-, disodiumsalt (9CI)
Biligrafin sodium
CHEMBL1200350
CTK4F3478
disodium 3-[[6-(3-carboxylato-2,4,6-triiodoanilino)-6-oxohexanoyl]amino]-2,4,6-triiodobenzoate
DISODIUM 3-{5-[(3-CARBOXYLATO-2,4,6-TRIIODOPHENYL)CARBAMOYL]PENTANAMIDO}-2,4,6-TRIIODOBENZOATE
Disodium 3,3'-((1,6-dioxo-1,6-hexanediyl)diimino)bis(2,4,6-triiodobenzoate)
Disodium N,N'-adiphylbis(3-amino-2,4,6-triiodobenzoic acid)
disodium3,3'-[ diimino]bis[2,4,6-triiodobenzoate]
EINECS 220-049-3
Iodipamide disodium salt
Iodipamide sodium
Iodipamide sodium [USP]
Iodipamide, disodium salt
LP082803
LS-35556
SCHEMBL3855758
Sodium 3,3'-(adipoylbis(azanediyl))bis(2,4,6-triiodobenzoate)
Sodium iodipamide
UNII-3J6WZA9PXS

US Patents and Regulatory Information for CHOLOGRAFIN SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco CHOLOGRAFIN SODIUM iodipamide sodium INJECTABLE;INJECTION 009321-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
McKesson
Mallinckrodt
McKinsey
Johnson and Johnson
Queensland Health
Daiichi Sankyo
Argus Health
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.